Epigenetic Therapy Targets Endocrine-Resistant Breast Cancer

被引：0
|
作者：
机构：
来源：
Genetic Engineering and Biotechnology News | 2024年 / 44卷 / 04期
关键词：
D O I：
10.1089/gen.44.04.12
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
相关论文
共 50 条
  • [1] Epigenetic Reprogramming of HOXC10 in Endocrine-Resistant Breast Cancer
    Pathiraja, Thushangi N.
    Nayak, Shweta R.
    Xi, Yuanxin
    Jiang, Shiming
    Garee, Jason P.
    Edwards, Dean P.
    Lee, Adrian V.
    Chen, Jian
    Shea, Martin J.
    Santen, Richard J.
    Gannon, Frank
    Kangaspeska, Sara
    Jelinek, Jaroslav
    Issa, Jean-Pierre J.
    Richer, Jennifer K.
    Elias, Anthony
    McIlroy, Marie
    Young, Leonie S.
    Davidson, Nancy E.
    Schiff, Rachel
    Li, Wei
    Oesterreich, Steffi
    SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (229)
  • [2] The potential of epigenetic therapy to target the 3D epigenome in endocrine-resistant breast cancer
    Joanna Achinger-Kawecka
    Clare Stirzaker
    Neil Portman
    Elyssa Campbell
    Kee-Ming Chia
    Qian Du
    Geraldine Laven-Law
    Shalima S. Nair
    Aliza Yong
    Ashleigh Wilkinson
    Samuel Clifton
    Heloisa H. Milioli
    Sarah Alexandrou
    C. Elizabeth Caldon
    Jenny Song
    Amanda Khoury
    Braydon Meyer
    Wenhan Chen
    Ruth Pidsley
    Wenjia Qu
    Julia M. W. Gee
    Anthony Schmitt
    Emily S. Wong
    Theresa E. Hickey
    Elgene Lim
    Susan J. Clark
    Nature Structural & Molecular Biology, 2024, 31 : 498 - 512
  • [3] The potential of epigenetic therapy to target the 3D epigenome in endocrine-resistant breast cancer
    Achinger-Kawecka, Joanna
    Stirzaker, Clare
    Portman, Neil
    Campbell, Elyssa
    Chia, Kee-Ming
    Du, Qian
    Laven-Law, Geraldine
    Nair, Shalima S.
    Yong, Aliza
    Wilkinson, Ashleigh
    Clifton, Samuel
    Milioli, Heloisa H.
    Alexandrou, Sarah
    Caldon, C. Elizabeth
    Song, Jenny
    Khoury, Amanda
    Meyer, Braydon
    Chen, Wenhan
    Pidsley, Ruth
    Qu, Wenjia
    Gee, Julia M. W.
    Schmitt, Anthony
    Wong, Emily S.
    Hickey, Theresa E.
    Lim, Elgene
    Clark, Susan J.
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2024, 31 (03) : 498 - 512
  • [4] New Targets in Endocrine-Resistant Hormone Receptor-Positive Breast Cancer
    Kennedy, Laura C.
    Mayer, Ingrid A.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (08) : 511 - 521
  • [5] Endocrine-Resistant Breast Cancer: Mechanisms and Treatment
    Hartkopf, Andreas D.
    Grischke, Eva-Maria
    Brucker, Sara Y.
    BREAST CARE, 2020, 15 (04) : 347 - 354
  • [6] Exploiting novel models of endocrine-resistant breast cancer to identify new therapeutic targets
    Soosainathan, Arany
    Nikitorowicz-Buniak, Joanna
    Pancholi, Sunil
    Iravani, Marjan
    Alexander, John
    Haider, Syed
    Johnston, Stephen R.
    Dowsett, Mitchell
    Martin, Lesley A.
    Isacke, Clare M.
    CANCER RESEARCH, 2022, 82 (04)
  • [7] Multiple endocrine-resistant breast cancer cell lines retain ER and sensitivity to endocrine therapy
    Gutgesell, Lauren M.
    Xiong, Rui
    Zhao, Jiong
    Zhao, Huiping
    Tonetti, Debra A.
    Thatcher, Gregory R.
    CANCER RESEARCH, 2018, 78 (13)
  • [8] The NFκB pathway and endocrine-resistant breast cancer
    Zhou, Y
    Eppenberger-Castori, S
    Eppenberger, U
    Benz, CC
    ENDOCRINE-RELATED CANCER, 2005, 12 : S37 - S46
  • [9] Gene expression profiles in endocrine-resistant breast cancer
    Schagerholm, C.
    Robertson, S.
    Sifakis, E. G.
    Hases, L.
    Williams, C.
    Hartman, J.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S640 - S640
  • [10] Breast cancer: Recurrent fusions in endocrine-resistant disease
    Romero D.
    Nature Reviews Clinical Oncology, 2018, 15 (4) : 200 - 200
12345